Emily earned her Bachelor’s degree in Biological Sciences with a Year in Industry at Imperial College London. During her third year of this degree, she completed an Industrial Placement in the Allergic Inflammation Discovery Performance Unit at GlaxoSmithKline.
In 2017, Emily joined the Wellcome Trust PhD programme in Cell Therapies and Regenerative Medicine at King's. She is currently investigating the impact of IBD-associated bacteria on the integrity of the gut epithelium and the inflammatory status of gut-resident immune cells, a collaborative project with Professor Mike Curtis.
During her PhD Emily has completed an internship at the Science Media Centre, a charity that aims to promote accurate, evidence-based scientific information in the media.